Skip to main content

Day: April 3, 2025

Grant of share-based long-term incentive instruments to members of the Board of Management and key employees

ALK (ALKB:DC / OMX: ALK B / AKBLF): According to the company’s remuneration policy adopted at the company’s Annual General Meeting on 14 March 2024 and in line with the company’s usual practice, the Board of Directors has passed a resolution to grant up to a total of 250,000 share-based instruments for the purpose of the company’s long-term incentive plan (LTIP) for the Board of Management and key employees for 2025. The objectives of the LTIP are to incentivise and reward long-term value creation and to align the interests of the Board of Management and key employees with shareholders’ interest by fulfilling the company’s strategic goals. The grant of share-based instruments under the LTIP is based on principles supporting the long-term strategy of ALK in accordance with the company’s remuneration policy. The share-based...

Continue reading

Form 8.3 – Advanced Medical Solutions Group Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Advanced Medical Solutions Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 02 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle™ AD study Data on the Elecsys® pTau181 plasma test demonstrate potential to accurately rule out amyloid pathology, one of the hallmarks of Alzheimer’s disease Roche will initiate a Phase III programme for trontinemab later this year based on totality of dataBasel, 3 April 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna, Austria. Highlights included presentations from the ongoing trontinemab Phase Ib/IIa Brainshuttle™ AD study demonstrating dose-dependent rapid amyloid depletion from the brain and the potential of the Elecsys® pTau181 plasma test to rule out...

Continue reading

Invesco Ltd: Form 8.3 – Qualcomm Incorporated; Public dealing disclosure

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Qualcomm Incorporated  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Invesco Ltd: Form 8.3 – Invesco Ltd: Form 8.3 – DS Smith PLC; Public dealing disclosure; Public dealing disclosure

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree American Axle & Manufacturing Holdings, Inc.  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the...

Continue reading

Proceedings at the annual general meeting 2025

Announcement no. 06 2025 Copenhagen – 3 April 2025 – Agillic A/S On 3 April 2025, at 14:30 (CET), the annual general meeting was held at the company’s address Masnedøgade 22, DK-2100 Copenhagen, in accordance with the agenda of the notice. The board of directors appointed attorney-at-law Jakob Vig Schnack as chairman of the general meeting. The general meeting took the board of director’s report on Agillic A/S’ business activities during 2024 into consideration. The annual report for the financial year 2024 was presented to and adopted by the general meeting. The general meeting adopted the proposal to transfer the result of the financial year 2024 to the next financial year and that no dividend is paid out. Joar Welde, Jesper Genter Lohmann, Thorsten Köhler, Jan Juul and Andreas D. Sandbu were re-elected as members of the board of directors....

Continue reading

Ársreikningur Norðurþings og stofnana fyrir árið 2024

Norðurþing Reikningsskil Ársreikningur Norðurþings og stofnana fyrir árið 2024 Byggðarráð Norðurþings mun samþykkja ársreikning Norðurþings og stofnana sveitarfélagsins fyrir árið 2024 á fundi sínum þann 30. apríl 2025. Fyrri umræða um ársreikninginn fór fram í sveitarstjórn þann 3. apríl sl. Samkvæmt lögum ber að fjalla um ársreikninginn á tveimur fundum í sveitarstjórn og fer síðari umræða fram þann 8. maí 2025, þar sem staðfesting sveitarstjórnar á ársreikningnum er fyrirhuguð. Komi ekki fram mikilvægar viðbótarupplýsingar, sem geta haft áhrif á gerð ársreikningsins og/eða niðurstöður hans við afgreiðslu og samþykkt sveitarstjórnar munu endurskoðendur árita ársreikninginn með fyrirvaralausri áritun og sveitarstjórn staðfesta ársreikninginn í fyrirliggjandi mynd. Rekstrarafkoma samstæðu Norðurþings Rekstrartekjur sveitarfélagsins á árinu...

Continue reading

Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025

ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING3 APRIL 2025 at 16.20 EEST           Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025 At the Annual General Meeting of Orion Corporation held today, the following decisions were made:A dividend of EUR 1.64 per share was confirmed to be paid. The dividend is paid in two instalments. The proposals concerning the election and remuneration of the Board of Directors, the election and remuneration of the auditor and the sustainability reporting assurance provider, and the number of the members of the Board of Directors were approved. Kari Jussi Aho, Maziar Mike Doustdar, Ari Lehtoranta, Veli-Matti Mattila, Hilpi Rautelin, Eija Ronkainen, Henrik Stenqvist and Karen Lykke Sørensen were re-elected to the Board of Directors. Veli-Matti Mattila...

Continue reading

American Battery Technology Company Doubles Quarterly Production at Lithium-Ion Battery Recycling Facility

American Battery Technology Company Doubles Quarterly Production at Lithium-Ion Battery Recycling FacilityAn employee at the American Battery Technology Company’s lithium-ion battery recycling facility near Reno, Nevada unloads a critical shipment of batteries for recycling. The company has more than doubled production of recycled battery materials this past quarter, transitioning to 24/7 operations and recycling recurring shipments of large-scale batteries from strategic automotive OEMs.American Battery Technology Company is producing and selling low-impurity intermediate black mass and other recycled byproducts commercially.American Battery Technology Company has more than doubled production of recycled battery materials this past quarter at its lithium-ion battery recycling facility near Reno, Nevada. Pictured...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.